{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:13Z","timestamp":1791895513338,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut du Cancer de Montr\u00e9al"},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1267-3","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T23:02:59Z","timestamp":1556146979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate"],"prefix":"10.1186","volume":"14","author":[{"given":"Vincent Q.","family":"Trinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Benzerdjeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Chagnon-Monarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guila","family":"Delouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kougioumoutzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula","family":"Albadine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hovington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Fradet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Taussky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"2","key":"1267_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/modpathol.2015.146","volume":"29","author":"Masashi Kato","year":"2016","unstructured":"Kato M, Tsuzuki T, Kimura K, Hirakawa A, Kinoshita F, Sassa N, et al. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation. Modern Pathol. 2016;29(2):166-73.","journal-title":"Modern Pathology"},{"issue":"6","key":"1267_CR2","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/pros.22786","volume":"74","author":"K Kimura","year":"2014","unstructured":"Kimura K, Tsuzuki T, Kato M, Saito AM, Sassa N, Ishida R, et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate. 2014;74(6):680\u20137.","journal-title":"Prostate"},{"issue":"12","key":"1267_CR3","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/modpathol.3800702","volume":"19","author":"CC Guo","year":"2006","unstructured":"Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006;19(12):1528\u201335.","journal-title":"Mod Pathol"},{"issue":"7","key":"1267_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jcp.2009.065003","volume":"62","author":"PC Henry","year":"2009","unstructured":"Henry PC, Evans AJ. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications. J Clin Pathol. 2009;62(7):579\u201383.","journal-title":"J Clin Pathol"},{"issue":"10","key":"1267_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5858\/arpa.2015-0206-RA","volume":"139","author":"M Magers","year":"2015","unstructured":"Magers M, Kunju LP, Wu A. Intraductal carcinoma of the prostate: morphologic features, differential diagnoses, significance, and reporting practices. Arch Pathol Lab Med. 2015;139(10):1234\u201341.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"1267_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/pros.22906","volume":"75","author":"T Zhao","year":"2015","unstructured":"Zhao T, Liao B, Yao J, Liu J, Huang R, Shen P, et al. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? Prostate. 2015;75(3):225\u201332.","journal-title":"Prostate."},{"issue":"33","key":"1267_CR7","doi-asserted-by":"crossref","first-page":"55374","DOI":"10.18632\/oncotarget.19520","volume":"8","author":"J Zhao","year":"2017","unstructured":"Zhao J, Shen P, Sun G, Chen N, Liu J, Tang X, et al. The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy. Oncotarget. 2017;8(33):55374\u201383.","journal-title":"Oncotarget."},{"issue":"1","key":"1267_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pros.23438","volume":"78","author":"M Kato","year":"2018","unstructured":"Kato M, Kimura K, Hirakawa A, Kobayashi Y, Ishida R, Kamihira O, et al. Prognostic parameter for high risk prostate cancer patients at initial presentation. Prostate. 2018;78(1):11\u20136.","journal-title":"Prostate."},{"issue":"4","key":"1267_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"JI Epstein","year":"2017","unstructured":"Epstein JI, Amin MB, Reuter VE, Humphrey PA. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2017;41(4):e1\u20137.","journal-title":"Am J Surg Pathol"},{"key":"1267_CR10","doi-asserted-by":"crossref","unstructured":"Porter LH, Hashimoto K, Lawrence MG, Pezaro C, Clouston D, Wang H, et al. Intraductal carcinoma of the prostate can evade androgen-deprivation, with emergence of castrate tolerant cells. BJU Int. 2018;121(6):971-8.","DOI":"10.1111\/bju.14043"},{"issue":"12","key":"1267_CR11","doi-asserted-by":"publisher","first-page":"673 e9","DOI":"10.1016\/j.urolonc.2017.08.015","volume":"35","author":"BF Dinerman","year":"2017","unstructured":"Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, et al. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol. 2017;35(12):673 e9\u2013e14.","journal-title":"Urol Oncol"},{"issue":"10","key":"1267_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/pros.23513","volume":"78","author":"Vincent Q. Trinh","year":"2018","unstructured":"Trinh VQ, Sirois J, Benzerdjeb N, Mansoori BK, Grosset AA, Albadine R, et al. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival. Prostate. 2018;78(10):697-706.","journal-title":"The Prostate"},{"issue":"4","key":"1267_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/17512433.2018.1429265","volume":"11","author":"M Bandini","year":"2018","unstructured":"Bandini M, Fossati N, Gandaglia G, Preisser F, Dell\u2019Oglio P, Zaffuto E, et al. Neoadjuvant and adjuvant treatment in high-risk prostate cancer. Expert Rev Clin Pharmacol. 2018;11(4):425\u201338.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"1267_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.eururo.2017.01.039","volume":"72","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, et al. Adjuvant and salvage radiotherapy after radical prostatectomy in prostate Cancer patients. Eur Urol. 2017;72(5):689\u2013709.","journal-title":"Eur Urol"},{"issue":"2","key":"1267_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.eururo.2014.04.023","volume":"66","author":"BJ Trock","year":"2014","unstructured":"Trock BJ. Adjuvant radiation following radical prostatectomy: what are the known unknowns? Eur Urol. 2014;66(2):251\u20132.","journal-title":"Eur Urol"},{"key":"1267_CR16","unstructured":"National Comprehensive Cancer Network. Prostate Cancer (Version 1.2019). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf . Accessed 3 Mar 2019."},{"issue":"9858","key":"1267_CR17","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","volume":"380","author":"M Bolla","year":"2012","unstructured":"Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet. 2012;380(9858):2018\u201327.","journal-title":"Lancet."},{"issue":"34","key":"1267_CR18","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1200\/JCO.2014.58.8525","volume":"32","author":"SJ Freedland","year":"2014","unstructured":"Freedland SJ, Rumble RB, Finelli A, Chen RC, Slovin S, Stein MN, et al. Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2014;32(34):3892\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1267_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","volume":"66","author":"T Wiegel","year":"2014","unstructured":"Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A, et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial. Eur Urol. 2014;66(2):243\u201350.","journal-title":"Eur Urol"},{"issue":"9","key":"1267_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","volume":"50","author":"D Trudel","year":"2014","unstructured":"Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, van der Kwast TH. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. Eur J Cancer. 2014;50(9):1610\u20136.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1267_CR21","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1097\/PAS.0000000000000609","volume":"40","author":"Sara E. Wobker","year":"2016","unstructured":"Wobker SE, Epstein JI. Differential diagnosis of Intraductal lesions of the prostate. Am J Surg Pathol. 2016;40(6):e67-82.","journal-title":"The American Journal of Surgical Pathology"},{"key":"1267_CR22","volume-title":"AJCC cancer staging manual","year":"2010","unstructured":"BD ESB, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.","edition":"7"},{"issue":"2","key":"1267_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","volume":"76","author":"JM Michalski","year":"2010","unstructured":"Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, et al. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010;76(2):361\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1267_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","volume":"181","author":"IM Thompson","year":"2009","unstructured":"Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181(3):956\u201362.","journal-title":"J Urol"},{"issue":"13","key":"1267_CR25","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/cncr.30620","volume":"123","author":"MD Hurwitz","year":"2017","unstructured":"Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, et al. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: results of NRG oncology\/RTOG study 0621. Cancer. 2017;123(13):2489\u201396.","journal-title":"Cancer."},{"issue":"2","key":"1267_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/modpathol.2015.146","volume":"29","author":"M Kato","year":"2016","unstructured":"Kato M, Tsuzuki T, Kimura K, Hirakawa A, Kinoshita F, Sassa N, et al. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation. Mod Pathol. 2016;29(2):166\u201373.","journal-title":"Mod Pathol"},{"issue":"3","key":"1267_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/iju.13514","volume":"25","author":"Yukiko Murata","year":"2018","unstructured":"Murata Y, Tatsugami K, Yoshikawa M, Hamaguchi M, Yamada S, Hayakawa Y, et al. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. Int J Urol. 2018;25(3):284-9.","journal-title":"International Journal of Urology"},{"issue":"1","key":"1267_CR28","first-page":"5","volume":"108","author":"N Sakamoto","year":"2017","unstructured":"Sakamoto N, Ueda S, Mizoguchi H, Kawahara I, Kobayashi T, Hamaguchi M, et al. Significance of Intraductal carcinoma of the prostate in post-operative biochemical recurrence. Nihon Hinyokika Gakkai Zasshi. 2017;108(1):5\u201311.","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"10","key":"1267_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/pros.23513","volume":"78","author":"VQ Trinh","year":"2018","unstructured":"Trinh VQ, Sirois J, Benzerdjeb N, Mansoori BK, Grosset AA, Albadine R, et al. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival. Prostate. 2018;78(10):697\u2013706.","journal-title":"Prostate."},{"issue":"3","key":"1267_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/iju.13514","volume":"25","author":"Y Murata","year":"2018","unstructured":"Murata Y, Tatsugami K, Yoshikawa M, Hamaguchi M, Yamada S, Hayakawa Y, et al. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. Int J Urol. 2018;25(3):284\u20139.","journal-title":"Int J Urol"},{"issue":"1","key":"1267_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/iju.12605","volume":"22","author":"G Gandaglia","year":"2015","unstructured":"Gandaglia G, Karakiewicz PI, Briganti A, Trudeau V, Trinh QD, Kim SP, et al. Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol. 2015;22(1):89\u201395.","journal-title":"Int J Urol"},{"key":"1267_CR32","unstructured":"Ilic D, Evans SM, Allan CA, Jung JH, Murphy D, Frydenberg M. Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU Int. 2017;72(4):492-5."},{"issue":"19","key":"1267_CR33","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/cncr.28856","volume":"120","author":"A Kalbasi","year":"2014","unstructured":"Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, et al. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer. 2014;120(19):3089\u201396.","journal-title":"Cancer."},{"issue":"4","key":"1267_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/bju.14512","volume":"123","author":"Michel Wissing","year":"2018","unstructured":"Wissing M, Brimo F, Chevalier S, Scarlata E, McKercher G, O'Flaherty A, et al. Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer. BJU Int. 2019;123(4):624-31.","journal-title":"BJU International"},{"issue":"6","key":"1267_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.eururo.2013.05.025","volume":"64","author":"S Punnen","year":"2013","unstructured":"Punnen S, Cooperberg MR, D'Amico AV, Karakiewicz PI, Moul JW, Scher HI, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2013;64(6):905\u201315.","journal-title":"Eur Urol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1267-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T18:33:31Z","timestamp":1607366011000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1267-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1267-3","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee approval and consent to participate were obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"60"}}